AGP Picks
View all

The Africa Gazette
Provided by AGP

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 15, 2026

Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis
Jun. 15, 2026

Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis

Indeterminate GlobeNewswire
Vaxart to Showcase Oral Vaccine Platform and Strategic Vision at BIO 2026 and Taiwan Biotech Forum
Jun. 15, 2026

Vaxart to Showcase Oral Vaccine Platform and Strategic Vision at BIO 2026 and Taiwan Biotech Forum

Indeterminate GlobeNewswire
Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company
Jun. 15, 2026

Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company

Indeterminate GlobeNewswire
4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board
Jun. 15, 2026

4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board

Indeterminate GlobeNewswire
Surge Copper Announces Results of Berg Pre-Feasibility Study with After-Tax NPV8% of C$4.6 billion and 24% IRR
Jun. 15, 2026

Surge Copper Announces Results of Berg Pre-Feasibility Study with After-Tax NPV8% of C$4.6 billion and 24% IRR

Indeterminate GlobeNewswire
Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia
Jun. 15, 2026

Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia

Indeterminate GlobeNewswire
XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
Jun. 15, 2026

XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO

Indeterminate GlobeNewswire
Data Supporting Differentiated Profile of Deucrictibant in HAE Management Presented at EAACI 2026
Jun. 15, 2026

Data Supporting Differentiated Profile of Deucrictibant in HAE Management Presented at EAACI 2026

Indeterminate GlobeNewswire
Context Therapeutics Announces Positive Interim Efficacy and Safety Results from Ongoing Phase 1 Clinical Trial for CTIM-76
Jun. 15, 2026

Context Therapeutics Announces Positive Interim Efficacy and Safety Results from Ongoing Phase 1 Clinical Trial for CTIM-76

Indeterminate GlobeNewswire
First Atlantic Nickel Drills Second Large-Scale Awaruite (Ni-Fe-Co Alloy) Discovery at Alloy Max North, Pipestone XL Project, 5.2 km North of RPM Zone - Visible Awaruite Over 414-Meter Drill Hole Ending in Open Mineralization
Jun. 15, 2026

First Atlantic Nickel Drills Second Large-Scale Awaruite (Ni-Fe-Co Alloy) Discovery at Alloy Max North, Pipestone XL Project, 5.2 km North of RPM Zone - Visible Awaruite Over 414-Meter Drill Hole Ending in Open Mineralization

Indeterminate GlobeNewswire
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Jun. 15, 2026

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire
MEXC Releases June 2026 Proof of Reserves with 156.5% Average Reserve Ratio Across Major Assets
Jun. 15, 2026

MEXC Releases June 2026 Proof of Reserves with 156.5% Average Reserve Ratio Across Major Assets

Indeterminate GlobeNewswire
Fortuna obtains key environmental approval for Diamba Sud Gold Project in Senegal
Jun. 15, 2026

Fortuna obtains key environmental approval for Diamba Sud Gold Project in Senegal

Indeterminate GlobeNewswire
Enterome presents Phase 1/2 iNHL interim data at EHA demonstrating durable OncoMimics™-induced CD8 T cell responses and clinical activity
Jun. 15, 2026

Enterome presents Phase 1/2 iNHL interim data at EHA demonstrating durable OncoMimics™-induced CD8 T cell responses and clinical activity

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Africa Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.